Resistant hypertension remains a tough adversary in the fight against the global rise of cardiovascular disease, but updated ...

The December issue of the Journal of Cardiac Failure (JCF), now available, offers a robust lineup of original research, ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

The peptide commonly referred to as SNAP-8 (acetyl octapeptide-3) is a synthetic fragment derivative of SNAP-25, engineered ...

Smart Meter's Cellular RPM™ solution gives more than 180,000 eClinicalWorks providers the ability to seamlessly enroll patients, capture vitals, and monitor chronic conditions directly within the ...

Even in conditions where evidence has been mixed, like COPD, reviews suggest RPM is safe and acceptable and, when paired with regular clinician feedback, can reduce COPD-related admissions.

Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 ...

Acute respiratory distress syndrome (ARDS) remains a major challenge in critical care, with mortality rates often exceeding 35–40%. Mechanical ...

Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

Quality control processes are needed for meeting regulatory obligations. Outdated methods create inefficiencies that ...